Company: ARMP
Filing Date: 2025-08-13
Form Type: S-3
Source: 0001104659-25-077648
Chunk: 29

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: S-3
Chunk 29
---
preferred stock or debt securities, and the warrants may be attached to or separate from our common stock, preferred stock or debt securities.
While the terms summarized below will apply generally to any warrants that we may offer, we will describe the particular terms of any
series of warrants in more detail in the applicable prospectus supplement. The terms of any warrants offered under a prospectus supplement
may differ from the terms described below.

We will file as an exhibit
to the registration statement of which this prospectus is a part, or will incorporate by reference from reports that we file with the
SEC, the form of warrant agreement, including a form of warrant certificate, that describes the terms of the particular series of warrants
we are offering before the issuance of the related series of warrants. The following summaries of material provisions of the warrants
and the warrant agreements are subject to, and qualified in their entirety by reference to, all the provisions of the warrant agreement
and warrant certificate applicable to the particular series of warrants that we may offer under this prospectus. We urge you to read the
applicable prospectus supplements related to the particular series of warrants that we may offer under this prospectus, as well as any
related free writing prospectuses, and the complete warrant agreements and warrant certificates that contain the terms of the warrants.

General

We will describe in the applicable
prospectus supplement the terms of the series of warrants being offered, including:

| · | the offering price and aggregate number of warrants 
 offered;                                            |

| · | the currency for which the warrants may be purchased; |

| · | if applicable, the number of warrants issued                                                           
 with each share of common stock or preferred stock, or with the principal amount of any debt security; |

| · | if applicable, the date on and after which the                   
 warrants and the related shares will be separately transferable; |

| · | the number of shares of common stock or preferred                                                                           
 stock purchasable upon the exercise of one warrant and the price at which these shares may be purchased upon such exercise; |

| · | the effect of any merger, consolidation, sale                                    
 or other disposition of our business on the warrant agreements and the warrants; |

| · | the terms of any rights to redeem or call the 
 warrants;                                     |

| · | any provisions for changes to or adjustments                                      
 in the exercise price or number of shares issuable upon exercise of the warrants; |

| · | the dates on which the right to exercise the 
 warrants will commence and expire